Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals

International Journal of Clinical Pharmacy

Volumn 36, Issue 5, 2014, Pages 1031-1038

  Brazinha, Isabel ^a   Fernandez Llimos, Fernando ^b  

^a Hospital Doutor José Maria Grande   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

Clinical pharmacy; Organizational innovation; Pharmacists; Pharmacy Service, Hospital; Portugal; Qualitative research

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; CLINICAL PHARMACY; CONCEPTUAL FRAMEWORK; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL PHARMACY; HUMAN; INTERPERSONAL COMMUNICATION; MALE; PHARMACIST; PHARMACIST ATTITUDE; PORTUGAL; WORKLOAD; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; NONBIOLOGICAL MODEL; PROGRAM EVALUATION; YOUNG ADULT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, ORGANIZATIONAL; PHARMACY SERVICE, HOSPITAL; PORTUGAL; PROGRAM EVALUATION; YOUNG ADULT;

EID: 84911455751     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-9991-0     Document Type: Article

References (63)

1. The Tokyo Declaration (1993) Standards for quality of pharmacy services (FIP Guidelines for Good Pharmacy Practice, September 1993) and revised version FIP/WHO GPP (1997). http://wwww.fip.org/good_pharmacy_practice?page=statements. 03 Jul 2010.
2. (2009) The Basel Statements on the future of hospital pharmacy. Am J Health Syst Pharm 66(5 Suppl 3):S61-S66. doi:10.2146/ajhp080666.
3. Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–64.
4. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and hospital mortality rates. Pharmacotherapy. 2007;27(4):481–93.
5. American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816–7.
6. Moullin JC, Sabater-Hernandez D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Social Adm Pharm. 2013;9(6):989–95.
7. van Mil JW, Fernandez-Llimos F. What is ‘pharmaceutical care’ in 2013? Int J Clin Pharm. 2013;35(1):1–2.
8. American Pharmacists Association, National Association of Chain Drug Stores Foundation (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc 48(3):341–353.
9. Benrimoj SI, Feletto E, Gastelurrutia MA, Martinez-Martinez F, Faus MJ. A holistic and integrated approach to implementing cognitive pharmaceutical services. Ars Pharm. 2010;51(2):69–87.
10. Sabater-Hernandez D, Faus MJ, Fikri-Benbrahim N, Garcia-Cardenas V. Overall results of the Dader Pharmacotherapeutic Follow-Up Program data base: 2008. Aten Primaria. 2010;42(5):297–8.
11. Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273–80.
12. Armando P, Semeria N, Tenllado M, Sola N. Pharmacotherapeutic follow-up of patients in community pharmacies. Aten Primaria. 2005;36(3):129–34.
13. Chemello C, Aguilera M, Calleja-Hernandez MA, Faus MJ. Effect of pharmaceutical follow-up in patients with secondary hyperparathyroidism treated with cinacalcet. Farm Hosp. 2012;36(5):321–7.
14. Figueiredo IV, Moteiro C, Castel-Branco MM, Caramona MM, Fernandez-Llimos F. Medication follow-up in type 2 diabetes patients at a primary health care center. Pharm Care Esp. 2014;17(2):39–48.
15. LeBlanc JM, Seoane-Vazquez E, Dasta JF. Survey of hospital pharmacist activities outside of the United States. Am J Health Syst Pharm. 2007;64(16):1748–55.
16. Comité de rédaction sur les pharmacie hospitalaire canadiennes (2010) Rapport 2007–2008 sur les pharmacies hospitalières canadiennes. http://www.lillyhospitalsurvey.ca/hpc2/content/2008_report/2007-2008F%20full.pdf. 03 Jul 2010.
17. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: monitoring and patient education–2012. Am J Health Syst Pharm. 2013;70(9):787–803.
18. Stuchbery P, Kong DCM, DeSantis GN, Lo SK. Identification by observation of clinical pharmacists’ activities in a hospital inpatient setting. Pharm Pract. 2007;5(1):10–6.
19. Child D, Cantrill J, Cooke J. The effectiveness of hospital pharmacy in the UK: methodology for finding the evidence. Pharm World Sci. 2004;26(1):44–51.
20. Campbell G, Auyeung V, McRobbie D. Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 2013;35(5):688–91.
21. Silva CMM, Calleja HMA, Tuneu i Valls L, Fuentes CB, Gutierrez SJ, Faus DMJ. Drug therapy follow-up in patients admitted to a surgery department. Farm Hosp. 2004;28(3):154–69.
22. Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussieres JF, Faye A, Brion F. Pilot study about pharmaceutical care implantation in a general paediatric unit in a French hospital. France-Quebec collaboration and comparison. Arch Pediatr. 2007;14(4):345–53.
23. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L, Tulkens PM. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc. 2007;55(5):658–65.
24. Bosma L, Jansman FG, Franken AM, Harting JW, Van den Bemt PM. Evaluation of pharmacist clinical interventions in a Dutch hospital setting. Pharm World Sci. 2008;30(1):31–8.
25. Veggeland T, Dyb S. The contribution of a clinical pharmacist to the improvement of medication at a geriatric hospital unit in Norway. Pharm Pract. 2008;6(1):20–4.
26. Bergkvist Christensen A, Holmbjer L, Midlov P, Hoglund P, Larsson L, Bondesson A, Eriksson T. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010–8.
27. Hohmann C, Neumann-Haefelin T, Klotz JM, Freidank A, Radziwill R. Drug-related problems in patients with ischemic stroke in hospital. Int J Clin Pharm. 2012;34(6):828–31.
28. Ribeiro N, Cavaco P, Falcao F, editors (2008) Implementation of Dader methodology for pharmacotherapy follow-up in hospitalized geriatric patients. ESCP 36th European Symposium on Clinical Pharmacy‘Implementing Clinical Pharmacy in Community and Hospital Settings: Sharing the Experience; 2007; Istanbul, Turkey: Pharm World Sci 30: 649–740.
29. Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.
30. Fernandez-Llimos F, Silva TA. Implementation of the protocol on pharmaceutical care in diabetes in Portugal. Pharm World Sci. 2009;31(4):495.
31. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282(15):1458–65.
32. Cochrane LJ, Olson CA, Murray S, Dupuis M, Tooman T, Hayes S. Gaps between knowing and doing: understanding and assessing the barriers to optimal health care. J Contin Educ Health Prof. 2007;27(2):94–102.
33. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C. Changing pharmacists’ practice pattern: pharmacists’ implementation of pharmaceutical care factors. J Soc Adm Pharm. 1996;13:74–88.
34. van Mil JWF, De Boer WO, Tromp TFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract. 2001;9(3):163–8.
35. Rossing C, Hansen EH, Krass I. Barriers and facilitators in pharmaceutical care: perceptions and experiences among Danish community pharmacies. J Soc Adm Pharm. 2001;19:55–64.
36. Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.
37. Hidalgo J, Cámara D, Baena MI, Fajardo PC, Martínez-Martínez F. Barriers for implementing pharmacotherapy follow-up in community pharmacies from Granada (Spain). Seguim Farmacoter. 2005;3(3):144–9.
38. Gastelurrutia MA, Fernandez-Llimos F, García-Delgado P, Gastelurrutia P, Faus MJ, Benrimoj SI. Barriers and facilitators to the dissemination and implementation of cognitive services in Spanish community pharmacies. Seguim Farmacoter. 2005;3(2):65–77.
39. Lounsbery JL, Green CG, Bennett MS, Pedersen CA. Evaluation of pharmacists’ barriers to the implementation of medication therapy management services. J Am Pharm Assoc. 2009;49(1):51–8.
40. MacIntosh C, Weiser C, Wassimi A, Reddick J, Scovis N, Guy M, Boesen K. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc. 2009;49(1):26–30.
41. Blake KB, Madhavan SS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–31.
42. Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.
43. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.
44. Liekens S, Smits T, Laekeman G, Foulon V. Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. Int J Clin Pharm. 2012;34(3):452–9.
45. Cotter SM, Barber ND, McKee M, Chalmers CP. Factors influencing the provision of clinical pharmacy services in United Kingdom National Health Service hospitals. Int J Technol Assess Health Care. 1996;12(3):475–86.
46. Awad A, Al-Ebrahim S, Abahussain E. Pharmaceutical care services in hospitals of Kuwait. J Pharm Pharm Sci. 2006;9(2):149–57.
47. Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.
48. Roberts AS, Hopp T, Sorensen EW, Benrimoj SI, Chen TF, Herborg H, Williams K, Aslani P. Understanding practice change in community pharmacy: a qualitative research instrument based on organisational theory. Pharm World Sci. 2003;25(5):227–34.
49. Gastelurrutia MA, Fernandez-Llimos F, Benrimoj SI, Castrillon CC, Faus MJ. Barriers for the implementation of cognitive services in Spanish community pharmacies. Aten Primaria. 2007;39(9):465–70.
50. Borum F. Organization, power and change. Copenhagen: Handelshøjskolens Forlag; 1995.
51. Lundin RA, Soderholm A. A theory of the temporary organization. Scand J Manag. 1995;11(4):437–55.
52. Charmaz K, Bryant A. Grounded theory. In: Given LM, editor. In: the Sage Encyclopedia of qualitative research methods. Thousand Oaks, CA: Sage; 2008.
53. Lioness A. Thematic coding and analysis. In: Given LM, editor. The Sage Encyclopedia of qualitative research methods. Thousand Oaks: Sage; 2008.
54. Leavitt HJ. Applied organizational change in industry. In: March JG, editor. Handbook of organizations. New York: Rand McNally; 1965.
55. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study. Int J Clin Pharm. 2012;34(4):569–78.
56. Zardain E, del Valle MO, Loza MI, Garcia E, Lana A, Markham WA, Lopez ML. Psychosocial and behavioural determinants of the implementation of Pharmaceutical Care in Spain. Pharm World Sci. 2009;31(2):174–82.
57. Gouveia WA. Transition to managed care, part 2. Am J Health Syst Pharm. 1998;55(4):347.
58. Cousins D. Current status of the monitoring of medication practice. Am J Health Syst Pharm. 2009;66(5 Suppl 3):S49–56.
59. Fernandez-Llimos F, Faus MJ. From “drug-related problems” to “negative clinical outcomes”. Am J Health Syst Pharm. 2005;62(22):2348–50.
60. Ambrose PJ, Saya FG, Lovett LT, Tan S, Adams DW, Shane R. Evaluating the accuracy of technicians and pharmacists in checking unit dose medication cassettes. Am J Health Syst Pharm. 2002;59(12):1183–8.
61. van den Bemt PM, van den Broek S, van Nunen AK, Harbers JB, Lenderink AW. Medication reconciliation performed by pharmacy technicians at the time of preoperative screening. Ann Pharmacother. 2009;43(5):868–74.
62. Dualde E, Faus MJ, Santonja FJ, Fernandez-Llimos F. Effectiveness of a videoconference training course on implementing pharmacy services. Pharm World Sci. 2009;31(6):638–42.
63. Salgado TM, Moles R, Benrimoj SI, Fernandez-Llimos F. Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views. Nephrol Dial Transplant. 2013;28(2):397–404.